Eating more whole grains produced small but consistent improvements in several cardiometabolic risk factors across 87 randomized trials, according to a meta-analysis published in the European Heart Journal. Each additional 48 g per day of whole grains by dry weight was associated with lower LDL cholesterol, triglycerides, fasting glucose, systolic blood pressure, body weight and waist circumference, although most individual changes were modest.
The analysis pooled randomized trials rather than observational studies
Whole grains have long been associated with lower rates of cardiovascular disease and type 2 diabetes in observational studies. The challenge is separating the effect of the food itself from the many other differences between people who eat more whole grains and those who do not.
The new analysis focused only on randomized controlled trials, which are better suited to testing whether changing whole-grain intake directly alters risk factors.
The researchers searched five databases through November 1, 2024 and included randomized parallel or crossover trials lasting at least two weeks. Participants were adults aged 18 or older, and the trials compared higher whole-grain intake with lower-whole-grain diets, refined-grain comparators, usual diets, routine care or lifestyle advice.
In total, the review included 87 studies represented by 101 publications. The protocol had been registered prospectively in PROSPERO.
LDL cholesterol showed one of the clearest effects
When whole-grain interventions were compared directly with control diets, LDL cholesterol fell by an average of 0.13 mmol/L across 69 trials involving 5,932 participants.
That is roughly a 5 mg/dL reduction in LDL cholesterol.
The authors judged that reduction to exceed their prespecified threshold for a minimally important difference. Among the primary outcomes, LDL was the clearest example of a change that was statistically significant and large enough to cross the study’s clinical-importance threshold.
In the dose-response analysis, each additional 48 g per day of whole grains by dry weight was associated with a 0.07 mmol/L reduction in LDL cholesterol, or about 2.7 mg/dL.
The effect is much smaller than what would typically be expected from a statin or other dedicated lipid-lowering medication, but diet can influence several risk factors simultaneously and may complement rather than replace medical therapy.
That distinction is especially relevant because atherosclerosis can begin years before symptoms appear, making long-term control of LDL and other risk factors important.
Total cholesterol and triglycerides also fell
Each 48 g per day increase in whole-grain intake was associated with a 0.10 mmol/L reduction in total cholesterol and a 0.04 mmol/L reduction in triglycerides.
Those changes translate to roughly 3.9 mg/dL lower total cholesterol and 3.5 mg/dL lower triglycerides.
The certainty of evidence was rated high for total cholesterol and moderate for triglycerides.
Not every blood-lipid marker improved consistently. The dose-response analysis did not show the same clear pattern for all outcomes, and the authors emphasized that different grains may have different metabolic effects.
Blood pressure improved, but the average change was small
Whole-grain intake was also associated with lower systolic blood pressure.
For every additional 48 g per day by dry weight, systolic pressure fell by an average of 0.82 mmHg. In the conventional pairwise analysis comparing whole-grain interventions with control diets, systolic blood pressure was 1.50 mmHg lower on average across 46 trials involving 3,609 participants.
The authors classified those changes as statistically significant but clinically small for an individual person.
A reduction of less than 1 or 2 mmHg is unlikely to transform one person’s cardiovascular risk on its own. At a population level, however, small shifts in blood pressure can still matter when they occur across millions of people.
Fasting glucose improved slightly, but HbA1c did not show the same signal
Each 48 g per day increment of whole grains was associated with a 0.03 mmol/L reduction in fasting plasma glucose, equivalent to about 0.5 mg/dL.
In the pairwise analysis, whole-grain interventions reduced fasting glucose by 0.07 mmol/L, about 1.3 mg/dL, compared with control diets.
The authors considered this reduction clinically small.
Importantly, the findings should not be interpreted as showing that whole grains dramatically lower blood sugar or reverse diabetes. The dose-response analysis did not show a clear improvement for every glycemic marker, including HbA1c.
For people with type 2 diabetes, whole grains would be one component of a broader dietary and treatment strategy. Bites of Bio recently covered a randomized trial in which a low-calorie diet combined with structured exercise put early-onset type 2 diabetes into remission in more than half of participants, illustrating how much more intensive an intervention may need to be to produce large metabolic changes.
Body weight changed by only a fraction of a kilogram
The meta-analysis also found statistically significant reductions in body weight and waist circumference.
Each additional 48 g per day of whole grains was associated with 0.20 kg lower body weight and 0.22 cm lower waist circumference.
In the pairwise analysis, whole-grain interventions lowered body weight by an average of 0.51 kg.
The researchers explicitly judged this weight difference to be below their threshold for clinical importance, which was 2.5 kg.
So this study should not be framed as evidence that simply adding whole grains produces meaningful weight loss.
Inflammation markers showed a mixed but potentially useful signal
Higher whole-grain intake was associated with a reduction in interleukin-6, or IL-6, an inflammatory signaling molecule.
Each 48 g per day increase was associated with a 0.12 pg/mL reduction in IL-6, with high-certainty evidence according to the authors’ GRADE assessment.
C-reactive protein and other inflammatory measures were less consistent, and some analyses had low or very low certainty.
The results therefore support a possible anti-inflammatory effect, but they do not establish that whole grains broadly suppress inflammation in a clinically meaningful way.
The largest effects appeared around 60 to 100 g per day
The researchers did more than compare high-intake and low-intake diets. They also modeled the shape of the dose-response relationship.
For many outcomes, the largest improvements appeared at around 60 to 100 g per day of whole grains by dry weight.
The authors estimated that this corresponds to roughly 115 to 190 g of whole-grain foods by fresh weight, or approximately four to six servings per day using the serving conversions applied in the paper.
That should not be interpreted as a newly established ideal dose for everyone.
The data became much sparser above about 140 g per day, producing wider confidence intervals. For several outcomes, the curve also continued to suggest possible benefits at intakes as high as 180 to 220 g per day, but there were too few trials at those levels to define a reliable upper threshold.
Forty-eight grams of whole grain does not mean 48 grams of bread
The dose numbers can be confusing because the study standardized exposure as dry-weight whole grain.
The authors treated 48 g per day of dry whole grain as approximately 90 g of whole-grain foods by fresh weight, or about three servings.
Actual food weights vary substantially depending on water content and preparation. Cooked oatmeal, brown rice, intact barley and whole-grain bread therefore cannot be compared gram-for-gram using the dry-weight figure.
The practical takeaway is better framed around replacing refined grains with foods in which the intact grain components are retained, rather than trying to weigh every serving to match the meta-analysis exactly.
Whole grains retain the bran, germ and endosperm
A whole grain contains the bran, germ and endosperm in roughly the same proportions as the intact kernel.
Refining typically removes the bran and germ, reducing fiber and altering the amount of vitamins, minerals and plant compounds that remain.
Different whole grains also contain different types of fiber and bioactive compounds. Oats and barley, for example, are particularly rich in beta-glucan, while wheat, rye, brown rice and other grains have different nutrient profiles.
This variability is one reason the researchers found substantial heterogeneity across some outcomes. The 87 trials did not test one standardized food.
Bites of Bio has previously looked at the broader shift toward minimally processed foods in why less-processed foods often outperform ultra-processed diets.
Most trials lasted only weeks
One of the biggest limitations is duration.
The median follow-up across the trials was only eight weeks.
That is long enough to measure changes in cholesterol, glucose or blood pressure, but not to determine whether eating more whole grains prevents heart attacks, strokes or diabetes over years.
The authors also reported that longer trials lasting at least 16 weeks sometimes showed smaller changes for certain outcomes. They suggested several possible explanations, including reduced adherence over time, behavioral compensation and lower statistical power.
The analysis measured risk factors, not heart attacks or strokes
This distinction is central to interpreting the study.
The randomized trials measured surrogate outcomes such as LDL cholesterol, blood pressure, glucose, body weight and inflammation. They were not trials of cardiovascular events or mortality.
It is therefore reasonable to say that whole grains improve several cardiovascular risk factors. It is not accurate to say that these 87 randomized trials proved that eating 60 to 100 g per day prevents heart attacks.
Long-term observational studies support an association between higher whole-grain intake and lower cardiovascular and diabetes risk, but those are a different type of evidence.
The trials varied substantially in foods, participants and comparators
The researchers reported heterogeneity across several analyses.
Some trials used oats, others wheat, rye, brown rice or mixed whole grains. Participants ranged from relatively healthy adults to people with obesity, diabetes or other cardiometabolic risk factors.
Control groups also differed. Some studies substituted refined grains, while others compared the intervention with a usual diet or general dietary advice.
Those differences make the meta-analysis more representative of real-world dietary research, but they also make it harder to identify which specific grain, food or substitution produced the benefit.
Adverse-event data were limited
The analysis did not find a clear increase in mild-to-moderate adverse events with higher whole-grain intake.
However, only seven trials involving 742 participants contributed to the main adverse-event analysis, and the certainty of that evidence was low.
Most of the included studies were also not designed to capture every gastrointestinal or subjective symptom systematically.
The study supports substitution more than supplementation
One practical issue is what whole grains replace.
Adding whole-grain foods on top of an unchanged diet is not necessarily the same as replacing refined bread, white rice or other refined-grain foods with whole-grain alternatives.
Many trials effectively tested substitution, and the health effect of a food often depends on the food it displaces.
This is also why broader dietary guidelines emphasize dietary patterns rather than treating one food as a supplement. Bites of Bio has summarized what changed in the 2025-2030 Dietary Guidelines.
The findings strengthen the evidence, but the effects are modest
The main strength of the new analysis is consistency across several independent cardiometabolic systems.
Whole-grain intake was associated with small improvements in LDL cholesterol, total cholesterol, triglycerides, fasting glucose, systolic blood pressure, body weight, waist circumference and IL-6.
No single change was dramatic. But dietary interventions do not necessarily need a large effect on one biomarker to be useful. Small shifts across several risk factors, sustained over years, may be more meaningful than the short-term numbers suggest.
That long-term implication remains an inference, not something these trials directly tested.
The study was publicly funded and authors reported no conflicts
The meta-analysis was funded by Tabriz University of Medical Sciences in Iran. According to the paper, the funder had no role in the study design, analysis, interpretation or publication decision.
All authors declared no personal or financial conflicts of interest.
References
- Naghshi S, Kiani S, Ostadrahimi A, et al. Whole-grain consumption and cardiometabolic risk: a meta-analysis of randomized trials. European Heart Journal. 2026. DOI: 10.1093/eurheartj/ehag519.
- American College of Cardiology. Whole-Grain Intake Tied to Improved Cardiometabolic Risk Factors in Meta-Analysis. September 21, 2026. ACC journal scan.